Core Laboratories N.V. (CLB) |
| 19 0.215 (1.14%) 01-13 16:00 |
| Open: | 19.02 |
| High: | 19.2 |
| Low: | 18.79 |
| Volume: | 184,471 |
| Market Cap: | 886(M) |
| PE Ratio: | 27.94 |
| Exchange: | New York Stock Exchange |
| Industry: | Oil & Gas Equipment & Services |
| Sector: | Energy |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 22.54 |
| Resistance 1: | 19.30 |
| Pivot price: | 17.43 |
| Support 1: | 17.02 |
| Support 2: | 15.61 |
| 52w High: | 20.82 |
| 52w Low: | 9.72 |
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
| EPS | 0.680 |
| Book Value | 5.890 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.217 |
| Profit Margin (%) | 6.21 |
| Operating Margin (%) | 11.91 |
| Return on Assets (ttm) | 5.0 |
| Return on Equity (ttm) | 12.3 |
Tue, 13 Jan 2026
HAL - Core Labs Matches EPS, Misses Rev - Analyst Blog - ADVFN
Tue, 13 Jan 2026
HAL - Core Laboratories a Penny Ahead - Analyst Blog - ADVFN
Tue, 13 Jan 2026
HAL - Core Labs Posts Strong 2Q - Analyst Blog - ADVFN
Tue, 06 Jan 2026
Core Laboratories (NYSE:CLB) Stock Passes Above Two Hundred Day Moving Average - Time to Sell? - MarketBeat
Mon, 05 Jan 2026
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL - Yahoo Finance
Thu, 23 Oct 2025
Earnings call transcript: Core Laboratories misses Q3 2025 earnings expectations - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |